All good.
I do see a difference between the second last line labelled Imputed cash flow3 of $54m and EBITDA for the quarter of $70m.
Which makes a difference.
Still I expect over the course of a year a lot of this will share itself out and lets just say the share appears remarkably under-priced relative to peers. (To some extent depending who we count as peers).
Note 3
- Forums
- ASX - By Stock
- MLX
- Ann: Quarterly Activities Report
MLX
metals x limited
Add to My Watchlist
0.00%
!
54.5¢

Ann: Quarterly Activities Report, page-21
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
54.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $483.0M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3600 | 56.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.0¢ | 3 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3593 | 0.560 |
5 | 89000 | 0.555 |
3 | 70814 | 0.550 |
6 | 99600 | 0.545 |
6 | 102377 | 0.540 |
Price($) | Vol. | No. |
---|---|---|
0.510 | 3 | 1 |
0.540 | 40000 | 1 |
0.545 | 61008 | 2 |
0.550 | 167671 | 5 |
0.555 | 75775 | 3 |
Last trade - 09.42am 27/06/2025 (20 minute delay) ? |
Featured News
MLX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online